Vertex Pharmaceuticals Inc.'s hepatitis C drug telaprevir, which won the endorsement last week of an expert panel of Food and Drug Administration advisers, has been given its brand name: Incivek (pronounced in-see-veck). FDA's decision on whether to grant final approval of the drug is expected May 23.
Back to other news for May 2011
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy